LIfT BioSciences
Phase 1LIfT Biosciences is a pre-clinical stage biotech with The World’s only Neutrophil based Cell Therapy Platform. The LIfT platform is allogeneic and can be used to produce different Immuno-Modulating Alpha Neutrophils (IMANs) for treating a range of different therapeutic indications, including solid tumours.
Founded
2017
Focus
Cell & Gene Therapy
About
LIfT Biosciences is a pre-clinical stage biotech with The World’s only Neutrophil based Cell Therapy Platform. The LIfT platform is allogeneic and can be used to produce different Immuno-Modulating Alpha Neutrophils (IMANs) for treating a range of different therapeutic indications, including solid tumours.
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2017
LocationLondon, United Kingdom
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile